Press Release

HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Receives Its First Regulatory Approval

HemeSight® hematological malignancies gene panel test approved in Japan

Novel Treatment for Drug-Resistant Bacteria and Inflammatory Bowel Disease Using Gut Microbiota: Suppression of Enterobacteriaceae by Controlling the Gut Environment

"COVID-19 Task Force" – Large-Scale Identification of Human Genomic Sequences Contributing to Individual Differences in Plasma Protein Levels

Effectiveness of Robot-Assisted Preventive Care Program Revealed—33% Increase in Normal Walking Speed

Discovery of Nuclear Envelope and Nuclear Pore Complex Defects as a Novel Therapeutic Target for Amyotrophic Lateral Sclerosis (ALS) - Uncovering Pathophysiological Clues from Genome-Edited Mice, iPS Cells, and Pathological Samples

Keio University Collaborates with Carnegie Mellon University and Industry to Establish a Research Center to Lead Next-Generation AI

Additional Rest After Subjective Sickness Subsides Leads to Sickness Reduction—Hopes for Efficient Simulator Sickness Reduction—

Successful Transmission Experiment in a Proof-of-Concept Study for Next-Generation In-Vehicle Optical Communication Systems—High-Speed In-Vehicle Optical Communication Systems to Support Fully Autonomous Driving—

September 21 is World Alzheimer's Day: Tackling Young-Onset Dementia in the Prime of Life—Keio University Hospital Memory Center Launches Crowdfunding Campaign

Next Generation In-vehicle Optical Communication System Demonstrated in Proof-of-concept Experiment―High-Speed In-Vehicle Optical Communication System Supports Fully Automated Driving―